Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Evaluation of the reported rates of hypersensitivity reactions associated with iron dextran and ferric carboxymaltose based on global data from VigiBase™ and IQVIA™ MIDAS® over a ten-year period from 2008 to 2017.
Expert Rev Hematol. 2020 May;13(5):557-564. doi: 10.1080/17474086.2020.1738215. Epub 2020 Mar 17.
Expert Rev Hematol. 2020.
PMID: 32129113
Comment on 'Evaluation of the Reported Rates of Severe Hypersensitivity Reactions Associated with Ferric Carboxymaltose and Iron(III) Isomaltoside 1000 in Europe Based on Data from EudraVigilance and VigiBase™ Between 2014 and 2017'.
Schaffalitzky de Muckadell P, Strom CC.
Schaffalitzky de Muckadell P, et al.
Drug Saf. 2019 May;42(5):689-691. doi: 10.1007/s40264-019-00814-5.
Drug Saf. 2019.
PMID: 30937852
Free PMC article.
No abstract available.
Item in Clipboard
Comment on 'Reported Severe Hypersensitivity Reactions after Intravenous Iron Administration in the European Economic Area (EEA) Before and After Implementation of Risk Minimization Measures'.
Schaffalitzky de Muckadell P, Strom CC.
Schaffalitzky de Muckadell P, et al.
Drug Saf. 2020 May;43(5):503-505. doi: 10.1007/s40264-020-00929-0.
Drug Saf. 2020.
PMID: 32253716
Free PMC article.
No abstract available.
Item in Clipboard
Cite
Cite